DR. YAKOV ISAKOV
Prescription History 1205096310
Psychiatry & Neurology - Neurology in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. YAKOV ISAKOV, an active Neurology specialist practicing in New York, NY. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 85 documented patient claims. Among these therapy options, the most frequently utilized medication is Glatiramer Acetate, which accounts for 34 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Glatiramer Acetate | 34 | $4,420.58 | ▲ More than typical |
About Glatiramer Acetate: This medication is used to treat multiple sclerosis (MS). Show more ▾ It is a protein that is thought to work by preventing your immune system from attacking the nerves in your brain and spinal cord. This effect can decrease the number of periods of disease worsening (relapses) and prevent or delay disability. It is not a cure for MS. A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS. In 2023, this provider wrote 34 Medicare prescriptions for Glatiramer Acetate, about 1.5 times the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $4,420.58 per fill, versus $4,109.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 976 Days of Medication total across all patients in 2023 | |||
| Dalfampridine ErDalfampridine | 21 | $956.74 | ▼ Less than typical |
About Dalfampridine Er: Dalfampridine is used to improve walking in people with multiple sclerosis (MS). Show more ▾ It is a potassium channel blocker. It is thought to work by improving nerve conduction. One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. In 2023, this provider wrote 21 Medicare prescriptions for Dalfampridine Er, about half the volume of the typical New York prescriber of this medication (46). Medicare paid an average of $956.74 per fill, versus $820.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| Dimethyl Fumarate | 18 | $1,305.57▼ below NY avg | ≈ Typical |
About Dimethyl Fumarate: Dimethyl fumarate is used to treat multiple sclerosis (MS). Show more ▾ It is not a cure for MS. It helps decrease the number of episodes of worsening MS. A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS. In 2023, this provider wrote 18 Medicare prescriptions for Dimethyl Fumarate, about 75% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $1,305.57 per fill, versus $2,839.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Baclofen | 12 | $8.08▼ below NY avg | ▼ Less than typical |
About Baclofen: Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). Show more ▾ It works by helping to relax the muscles. A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. In 2023, this provider wrote 12 Medicare prescriptions for Baclofen, about a third of the volume of the typical New York prescriber of this medication (39). Medicare paid an average of $8.08 per fill, versus $28.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. YAKOV ISAKOV is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
